This federal contract award is a delivery order valued at $11,263.20 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product, with a completion date of December 20, 2024.
The award is not associated with a set-aside designation and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This award for the TYPHIM VI vaccine is part of DMS Pharmaceutical Group's extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables provided to the Department of Defense through its federal contract awards.
Generated 3/20/25, 10:52 AM